Literature DB >> 29306771

Stage-specific incidence and survival of breast cancer in Norway: The implications of changes in coding and classification practice.

Inger Kristin Larsen1, Tor Åge Myklebust2, Tom Børge Johannesen3, Bjørn Møller4, Solveig Hofvind5.   

Abstract

To describe the association between coding and classification practices and observed stage-specific incidence and survival trends in Norway over time. We identified all women diagnosed with invasive breast cancer in the period between 1980 and 2015. Changes in the coding and classification of breast cancer in the study period were described, and stage-specific incidence rates and relative survival were calculated. A total of 90 362 women were diagnosed with primary breast cancer, stage I-IV, or unknown stage, in the study period. Stage-specific incidence was significantly influenced by changes in coding practice, classification systems and the implementation of the screening program. These changes have mostly affected the proportion of stage I and "unknown", but also stages II, III and IV. The proportion of stage I showed a clear increase during the implementation period of the national screening program, and was most pronounced within the age group 50-69. Stage-specific trends for relative survival were less influenced by changes in coding and classification of stage. Our study showed that the stage-specific incidence trends in Norway were influenced by changes in the coding and classification practice. These findings should be taken into consideration in future research and evaluation related to stage-specific trends and stage migration of breast cancer in Norway.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Incidence; Stage; Survival

Mesh:

Year:  2018        PMID: 29306771     DOI: 10.1016/j.breast.2017.12.001

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  11 in total

1.  Secondary and Quaternary Delays in the Diagnosis of Breast Cancer: Are the Physicians Responsible too?

Authors:  Soumen Das; Radha Raman Mondal; Abhimanyu Basu
Journal:  Indian J Surg Oncol       Date:  2022-03-02

2.  Stage-specific survival has improved for young breast cancer patients since 2000: but not equally.

Authors:  Cassia Bree Trewin; Anna Louise Viktoria Johansson; Kirsti Vik Hjerkind; Bjørn Heine Strand; Cecilie Essholt Kiserud; Giske Ursin
Journal:  Breast Cancer Res Treat       Date:  2020-06-03       Impact factor: 4.872

3.  Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.

Authors:  Yngvar Nilssen; Odd Terje Brustugun; Morten Tandberg Eriksen; Erik Skaaheim Haug; Bjørn Naume; Bjørn Møller
Journal:  BMC Cancer       Date:  2020-05-30       Impact factor: 4.430

Review 4.  The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

Authors:  M J M Broeders; P Allgood; S W Duffy; S Hofvind; I D Nagtegaal; E Paci; S M Moss; L Bucchi
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

5.  Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.

Authors:  Nina Gran Egeland; Marie Austdal; Bianca van Diermen-Hidle; Emma Rewcastle; Einar G Gudlaugsson; Jan P A Baak; Ivar Skaland; Emiel A M Janssen; Kristin Jonsdottir
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

6.  In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study.

Authors:  Hege Russnes; Giske Ursin; Anna L V Johansson; Cassia B Trewin; Irma Fredriksson; Kristin V Reinertsen
Journal:  Breast Cancer Res       Date:  2021-02-01       Impact factor: 6.466

7.  Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study.

Authors:  Anton Ryzhov; Marilys Corbex; Marion Piñeros; Anton Barchuk; Diana Andreasyan; Sayde Djanklich; Vadim Ghervas; Olga Gretsova; Dilyara Kaidarova; Konstantin Kazanjan; Fuad Mardanli; Yuriy Michailovich; Elena Ten; Alesya Yaumenenka; Freddie Bray; Ariana Znaor
Journal:  Lancet Oncol       Date:  2021-02-05       Impact factor: 41.316

8.  Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.

Authors:  Yngvar Nilssen; Odd Terje Brustugun; Morten Tandberg Eriksen; Marianne G Guren; Erik Skaaheim Haug; Bjørn Naume; Ellen Schlichting; Bjørn Møller
Journal:  BMC Cancer       Date:  2022-02-28       Impact factor: 4.430

9.  Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway.

Authors:  Yngvar Nilssen; Morten Tandberg Eriksen; Marianne G Guren; Bjørn Møller
Journal:  BMC Cancer       Date:  2021-06-30       Impact factor: 4.430

10.  Factors associated with emergency-related diagnosis, time to treatment and type of treatment in 5713 lung cancer patients.

Authors:  Yngvar Nilssen; Odd T Brustugun; Bjørn Møller
Journal:  Eur J Public Health       Date:  2021-10-26       Impact factor: 3.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.